Ryan T. Mott, MD

Associate Professor, Pathology

Research

Publications

Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Renfrow JJ, Soike MH, West JL, Ramkissoon SH, Metheny-Barlow L, Mott RT, Kittel CA, D'Agostino RB, Tatter SB, Laxton AW, Frenkel MB, Hawkins GA, Herpai D, Sanders S, Sarkaria JN, Lesser GJ, Debinski W, Strowd RE. Sci Rep. 2020 09; 10(1):15195.
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?. Soike MH, McTyre ER, Shah N, Puchalski RB, Holmes JA, Paulsson AK, Miller LD, Cramer CK, Lesser GJ, Strowd RE, Hinson WH, Mott RT, Johnson AJ, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD. Neuroradiology. 2018 Oct; 60(10):1043-1051.
Hypoxia-inducible factor 2a: a novel target in gliomas. Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE. Future Med Chem. 2018 09; 10(18):2227-2236.
Pearls & Oy-sters: The critical role of histopathology in diagnosing cancer-associated necrotizing CNS vasculitis. Sheehan J, Tate J, Mott R, Geer C, Wolfe R, Strowd RE, Guzik A. Neurology. 2018 04; 90(17):808-811.
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures. Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J, Daniel S, Covert M, Frampton GM, Hsu S, Lesser GJ, Stogner-Underwood K, Mott RT, Rush SZ, Stanke JJ, Dahiya S, Sun J, Reddy P, Chalmers ZR, Erlich R, Chudnovsky Y, Fabrizio D, Schrock AB, Ali S, Miller V, Stephens PJ, Ross J, Crawford JR, Ramkissoon SH. Oncologist. 2017 12; 22(12):1478-1490.

View More Publications

Technology Transfer and Commercialization

Research Focus Areas

Translation to Care

More Resources

Ryan T. Mott, MD